Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA: 600420)
China flag China · Delayed Price · Currency is CNY
12.88
-0.02 (-0.16%)
Nov 13, 2024, 3:00 PM CST

Shanghai Shyndec Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
17,27413,1309,34610,6509,7669,181
Upgrade
Market Cap Growth
26.94%40.50%-12.25%9.04%6.38%-4.90%
Upgrade
Enterprise Value
14,88410,58210,42312,75411,74310,392
Upgrade
Last Close Price
12.889.608.859.989.068.43
Upgrade
PE Ratio
15.9617.6816.3020.6716.4614.78
Upgrade
PS Ratio
1.501.090.720.760.780.75
Upgrade
PB Ratio
1.320.920.771.030.991.00
Upgrade
P/FCF Ratio
8.499.633.679.198.2610.60
Upgrade
P/OCF Ratio
7.647.633.276.346.267.23
Upgrade
EV/Sales Ratio
1.290.880.800.910.940.85
Upgrade
EV/EBITDA Ratio
6.415.996.246.876.455.59
Upgrade
EV/EBIT Ratio
9.7210.9412.3911.8310.729.13
Upgrade
EV/FCF Ratio
7.317.764.0911.019.9312.00
Upgrade
Debt / Equity Ratio
0.070.080.280.400.390.51
Upgrade
Debt / EBITDA Ratio
0.490.642.022.202.092.51
Upgrade
Debt / FCF Ratio
0.560.841.343.613.225.39
Upgrade
Asset Turnover
0.590.620.670.750.700.72
Upgrade
Inventory Turnover
3.093.192.942.492.422.69
Upgrade
Quick Ratio
1.612.152.121.091.041.08
Upgrade
Current Ratio
2.512.822.781.591.641.49
Upgrade
Return on Equity (ROE)
9.30%7.28%7.70%8.13%9.46%10.52%
Upgrade
Return on Assets (ROA)
4.89%3.10%2.72%3.61%3.81%4.17%
Upgrade
Return on Capital (ROIC)
6.04%3.90%3.49%4.78%4.98%5.64%
Upgrade
Earnings Yield
6.27%5.27%6.72%5.34%6.64%7.15%
Upgrade
FCF Yield
11.78%10.38%27.27%10.88%12.10%9.44%
Upgrade
Dividend Yield
1.55%1.04%1.13%1.00%1.10%1.19%
Upgrade
Payout Ratio
21.82%27.37%29.42%37.39%32.42%49.44%
Upgrade
Buyback Yield / Dilution
-9.07%-10.13%1.82%0.14%-2.42%-5.45%
Upgrade
Total Shareholder Return
-7.52%-9.09%2.95%1.14%-1.32%-4.27%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.